Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2012
04/04/2012CN102397350A 一种用于治疗肾炎合并肾功能低下症的药物 A drug treatment of nephritis and renal dysfunction disorders for
04/04/2012CN102397316A 一种治疗肾炎的中药配方 A method of treating nephritis Chinese medicine formula
04/04/2012CN102397314A 用于防治低海拔地区初生藏獒肾病的保健品 For the control of low-altitude Tibetan mastiff nephropathy newborn care products
04/04/2012CN102396784A 保健内裤、卫生巾及其制造方法 Health briefs, sanitary napkins and the manufacturing method
04/04/2012CN101940585B 一种以荭草素-2"-O-β-L-半乳糖苷为主要成分的组合物及其用途 Kind orientin prime -2 "-O-β-L- galactosidase as a main component a composition and use thereof
04/04/2012CN101843744B 一种治疗慢性肾功能衰竭的中药 A chronic renal failure herbal treatment
04/03/2012US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/03/2012US8148427 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
04/03/2012US8148355 Phophylactic and therapeutic use of hydroxysteroids
03/2012
03/29/2012WO2012039460A1 Substituted amide compound
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012038058A1 Treatment of conditions by toll-like receptor modulators
03/29/2012WO2012037603A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012US20120077985 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077735 Prophylactic agent for renal failure
03/29/2012US20120076863 Nanoparticulate stabilized anti-hypertensive compositions
03/29/2012US20120076836 Polyion complex of double-stranded ribonucleic acid
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076791 Methods Of Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811654A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012CA2810706A1 Substituted amide compound
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432474A1 Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain
03/28/2012EP2432468A2 Methods of modulating uric acid levels
03/28/2012EP2432465A1 Use of dynamin ring stabilizers
03/28/2012EP1807065B1 Methods and compositions for treating nephrogenic diabetes insipidus
03/28/2012EP1465688B9 Bicarbonate-based solutions for dialysis therapies
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395367A Use of nifuratel to treat infections caused by atopobium species
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN102391160A Metformin and 2,5-dihydroxybenzene sulfonate, and compound recipe composition thereof
03/28/2012CN102389531A Traditional Chinese medicine for curing chronic prostatitis
03/28/2012CN102389530A Traditional Chinese medicine for curing benign prostatic hyperplasia
03/28/2012CN102389525A Traditional Chinese medicine for curing benign prostatic hyperplasia
03/28/2012CN102389524A Chinese medicine for treating diabetic nephropathy
03/28/2012CN102389523A Traditional Chinese medicine for treating benign prostatic hyperplasia
03/28/2012CN102389522A Traditional Chinese medicine for treating prostatic hyperplasia
03/28/2012CN102389521A Chinese medicine for treating chronic prostatitis
03/28/2012CN102389477A Traditional Chinese medicine for treating benign prostatic hyperplasia
03/28/2012CN102389415A Application of iridoid compounds to preparation of medicine for treating benign prostatic hyperplasia
03/28/2012CN102389234A Myrica rubra kernel health care mattress
03/28/2012CN102100742B Water-solubility extract of root of red-rooted salvia, preparation method thereof and application thereof
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN102018736B Natural indigo decoction piece and preparation method thereof
03/28/2012CN101987162B Traditional Chinese medical preparation for treating anaphylatic purpura nephritis nephrotic syndrome
03/28/2012CN101816715B Method for measuring content of Danshensu in shenshuaining capsules by utilizing HPLC method
03/28/2012CN101721656B Medicine composition for curing lithiasis and preparation method thereof
03/27/2012US8143486 Delta-5 desaturase and uses thereof
03/27/2012US8143383 Δ-6 desaturase and uses thereof
03/27/2012US8143297 Heterocyclic derivatives as modulators of ion channels
03/27/2012US8143264 Xanthine derivatives as selective HM74A agonists
03/27/2012US8143240 17α, 21-dihydroxypregnene esters as antiandrogenic agents
03/27/2012US8143225 Incotinence; dosage form
03/27/2012US8143219 Methods for prevention and treatment of acute renal injury
03/22/2012WO2012037370A1 Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
03/22/2012WO2012035122A1 Anthraquinone compounds and their uses
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071538 Pharmaceutical formulatons
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071514 Benzoxazolone derivatives as aldosterone synthase inhibitors
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071501 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
03/22/2012US20120071413 TREATMENT OF CHRONIC NEPHROPATHIES USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120070517 Pharmaceutical composition containing herbal extract for prevention or treatment of nephritis
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070408 Methods and compositions for treating lupus
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012CA2812184A1 Anthraquinone compounds and their uses
03/22/2012CA2811291A1 Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2429499A2 Method for impregnation with supercrtitical co2
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1488808B1 Remedies for glomerular diseases
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN202169015U 膀胱经组织疾病的治疗装置 Treatment means the bladder tissue disease
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102382747A Chinese herbal health care wine and manufacturing method thereof
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102382128A Three-ring fused PI3K and mTOR dual inhibitor
03/21/2012CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 562